Investing.com -- Here is a summary of the most important regulatory news releases from the London Stock Exchange on Tuesday, 3rd December. Please refresh for updates.
- Fast fashion group boohoo.com (LON:BOOH) said it had had a record performance over the Thanksgiving Holiday weekend, boasting a “strong operational performance” at both its warehouses.
- As such, it said it “continues to trade comfortably in line with market expectations.”
- The company said it has successfully integrated the Karen Millen, Coast and Miss Pap brands into its platform since buying them earlier this year.
- Boohoo’s next update is scheduled for Jan. 14.
AstraZeneca (LON:AZN) said it has agreed to sell the U.S. and Canadian commercial rights for its off-patent drug Seroquel to Germany’s Cheplapharm Arzneimittel for an initial $35 million.
The price may rise to $41 million contingent on future sales of the drug, which is used to treat bipolar disorder and schizophrenia.
Cineworld (LON:CINE) revised its outlook for the full year “slightly” lower, without giving any more precise guidance, after a quarter dominated by a 12% currency-adjusted global drop in box office takings in the first 11 months of the year.
Revenue from U.S. theaters fell 14%, while the U.K. and Ireland held up better with only an 8.1% drop, while takings from the Rest of the World rose 1.2%.
Despite the disappointing numbers, Cineworld said the benefits from its acquisition of Regal cinemas were greater than it had expected. It now expects synergies of $190 million from that deal, rather than the $150 million initially expected.
It also added that its U.S. refurbishment program is on track, and that it expects 20 new sites to be completed within the next 12 months.